These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14417558)

  • 1. Effect of degree of encapsulation upon virulence of Cryptococcus neoformans.
    LITTMAN ML; TSUBURA E
    Proc Soc Exp Biol Med; 1959; 101():773-7. PubMed ID: 14417558
    [No Abstract]   [Full Text] [Related]  

  • 2. THE PREVALENCE AND MOUSE VIRULENCE OF CRYPTOCOCCUS NEOFORMANS STRAINS ISOLATED FROM URBAN AREAS.
    HASENCLEVER HF; EMMONS CW
    Am J Hyg; 1963 Sep; 78():227-31. PubMed ID: 14063725
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans.
    Huang W; Liao G; Baker GM; Wang Y; Lau R; Paderu P; Perlin DS; Xue C
    mBio; 2016 May; 7(3):. PubMed ID: 27165800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique cytoskeleton-associated protein in Cryptococcus neoformans.
    Gelli A
    Virulence; 2018 Dec; 9(1):752-753. PubMed ID: 29532702
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urease activity in Cryptococcus neoformans and Cryptococcus gattii].
    Torres-Rodríguez JM; Alvarado-Ramírez E; Gutiérrez-Gallego R
    Rev Iberoam Micol; 2008 Mar; 25(1):27-31. PubMed ID: 18338924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cryptococcus neoformans, var. neoformans, Cryptococcus neoformans var. gattii, causative agents of cryptococcosis].
    Swinne D; Lumbila M
    Bull Mem Acad R Med Belg; 1987; 142(2-3):238-48. PubMed ID: 3311260
    [No Abstract]   [Full Text] [Related]  

  • 7. Melanin and virulence in Cryptococcus neoformans.
    Casadevall A; Rosas AL; Nosanchuk JD
    Curr Opin Microbiol; 2000 Aug; 3(4):354-8. PubMed ID: 10972493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans.
    Steenbergen JN; Casadevall A
    Microbes Infect; 2003 Jun; 5(7):667-75. PubMed ID: 12787743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence and growth rates of Cryptococcus neoformans in mice.
    HASENCLEVER HF; MITCHELL WO
    Ann N Y Acad Sci; 1960 Aug; 89():156-62. PubMed ID: 13712109
    [No Abstract]   [Full Text] [Related]  

  • 10. Virulence and antifungal susceptibility of environmental and clinical isolates of Cryptococcus neoformans from Puerto Rico.
    Fromtling RA; Abruzzo GK; Ruiz A
    Mycopathologia; 1989 Jun; 106(3):163-6. PubMed ID: 2682249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcus neoformans MET5 Gene is not Essential for Virulence in the Silkworm Infection Model.
    Nguyen PT; Nguyen NH; Kang YQ; Shimizu K
    Med Mycol J; 2022; 63(3):77-80. PubMed ID: 36047186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility.
    Krysan DJ; Zhai B; Beattie SR; Misel KM; Wellington M; Lin X
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laccase and melanin in the pathogenesis of Cryptococcus neoformans.
    Williamson PR
    Front Biosci; 1997 Nov; 2():e99-107. PubMed ID: 9342305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological study of murine pulmonary cryptococcosis induced by Cryptococcus gattii and Cryptococcus neoformans.
    Okubo Y; Wakayama M; Ohno H; Yamamoto S; Tochigi N; Tanabe K; Kaneko Y; Yamagoe S; Umeyama T; Shinozaki M; Nemoto T; Nakayama H; Sasai D; Ishiwatari T; Shimodaira K; Yamamoto Y; Kamei K; Miyazaki Y; Shibuya K
    Jpn J Infect Dis; 2013; 66(3):216-21. PubMed ID: 23698482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms.
    Rodrigues ML; Alviano CS; Travassos LR
    Microbes Infect; 1999 Apr; 1(4):293-301. PubMed ID: 10602663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
    Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
    Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective involvement of the brain in experimental murine cryptococcosis. I. Microbiological observations.
    Staib F; Mishra SK
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):355-64. PubMed ID: 1101587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptococcus neoformans--pathogen and saprophyte.
    Campbell CK; Mackenzie DW
    Soc Appl Bacteriol Symp Ser; 1980; 9():249-58. PubMed ID: 7013081
    [No Abstract]   [Full Text] [Related]  

  • 19. Signal transduction pathways regulating differentiation and pathogenicity of Cryptococcus neoformans.
    Alspaugh JA; Perfect JR; Heitman J
    Fungal Genet Biol; 1998 Oct; 25(1):1-14. PubMed ID: 9806801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients.
    Staib F; Seibold M; Antweiler E; Fröhlich B; Weber S; Blisse A
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Aug; 266(1-2):167-77. PubMed ID: 3321763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.